The NIH GO grant fuels the McKnight Brain Institute’s Regeneration Project whose researchers look to tap unused human capacities to treat spinal cord injury, stroke, traumatic brain injury and other neural conditions.
Archive for 2009
A discovery in laboratory models suggest that the addition of a small molecule to the cancer drug Temozolomide disrupts repair mechanisms in a type of tumor cells that are highly resistant to treatment.
UF College of Medicine and Shands HealthCare infection control experts are taking precautions after discovering a type of bacteria that could cause adverse health effects in people with weakened immune systems. The bacteria was found in a sink in a patient room at the UF Shands Cancer Hospital.